Wall Street Beat
Orthofix CFO bails after 6 months amid deepening financial fix
TriVascular Tech recall of stent grafts may drag down full-year revenues | Medtech Wall Street news for the week of September 22, 2014
TriVascular Tech's stent graft recall could hurt the bottom line
September 19, 2014 by Arezu Sarvestani
Ackman threatens to sue Allergan again over potential Salix deal
Breast implant maker Sientra registers an $86M IPO
California medical device maker Sientra Inc. is looking to hit the public markets with an initial public offering that could raise as much as $86.3 million, according to an SEC filing.
Philips to carve out lighting biz, merge healthcare & consumer units
Medtronic, Covidien slide on new U.S. inversion rules
Alere unveils $3.82B privatization plan | MassDevice.com On Call
Medtronic stock continues to hit new highs this month
TriVascular Tech’s stent graft recall could hurt the bottom line
California medtech maker TriVascular Technologies (NSDQ:TRIV) issued an update today on the recall of certain of its Ovation Prime aortic stent grafts, advising that the measure may drag down full-year revenues.